Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

The alpha-synuclein ( α Syn) seeding amplification assay (SAA) that allows the generation of disease-specific in vitro seeded fibrils (SAA fibrils) is used as a research tool to study the connection between the structure of α Syn fibrils, cellular seeding/spreading, and the clinico-pathological manifestations of different synucleinopathies. However, structural differences between human brain-derived and SAA α Syn fibrils have been recently highlighted. Here, we characterize biophysical properties of the human brain-derived α Syn fibrils from the brains of patients with Parkinson’s disease with and without dementia (PD, PDD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA) and compare them to the ‘model’ SAA fibrils. We report that the brain-derived α Syn fibrils show distinct biochemical profiles, which were not replicated in the corresponding SAA fibrils. Furthermore, the brain-derived α Syn fibrils from all synucleinopathies displayed a mixture of- ‘straight’ and ‘twisted’ microscopic structures. However, the PD, PDD, and DLB SAA fibrils had a ‘straight’ structure, whereas MSA SAA fibrils showed a ‘twisted’ structure. Finally, the brain-derived α Syn fibrils from all four synucleinopathies were phosphorylated (S129). Interestingly, phosphorylated α Syn were carried over to the PDD and DLB SAA fibrils. Our findings demonstrate the limitation of the SAA fibrils modelling the brain-derived α Syn fibrils and pay attention to the necessity of deepening the understanding of the SAA fibrillation methodology.

Related topics